FDA OKs use of Abbott CGM system in hospitals

The FDA has signed off on the use of Abbott’s (ABT -0.0%) FreeStyle Libre 14 day continuous glucose monitoring system in the hospital setting during the COVID-19 pandemic, enabling frontline healthcare workers to remotely monitor inpatient diabetics.

The company is also donating 25K sensors to assist in ramp ups in hard-stricken areas.

https://seekingalpha.com/news/3559348-fda-oks-use-of-abbott-cgm-system-in-hospitals